Setting a new standard
An advanced FFR pressure guidewire with fiber optic sensing technology.
OptoWire Deux
Experience an entirely new level of productivity with OptoWire Deux . The first Nitinol based FFR pressure guidewire with fiber optic sensing technology.
- Optical coherence technology
- First Nitinol & stainless steel construction
- Reliable & fast recovery connectivity
OptoMonitor
Easy cathlab integration and intuitive workflow. OptoMonitor offers an intuitive step-by-step workflow with state of the art touch screen.
- Easy cathlab integration
- Intuitive workflow
- Perpetual system availability
Fractional Flow Reserve Facts
Our Expertise for the Benefit of Patients
Short film presented by Opsens as part of the International Medical Film Festival – Québec en Santé.
This film highlights the use of the OptoWire, Opsens’ optical pressure guidewire, to measure Fractional Flow Reserve (“FFR”) in a real-case situation.
DEFER study and the 5-year follow-up
A valid question. Is PCI necessary and beneficial for patient with a coronary stenosis without evidence of ischemia?
More details Read more about DEFER study and the 5-year follow-upFAME study
Improved outcomes. Using fractional flow reserve (FFR) measurements during stenting procedures reduced MACE by 28% and a strong trend towards a lower rate of death, MI or the need for repeat revascularization in the FFR guided approach.
More details Read more about DEFER study and the 5-year follow-upFAME II study
Better patient outcomes with FFR-Guided cardiac stenting. The use of FFR-guided PCI led to an 86 % decrease in risk of unplanned hospitalization for urgent revascularization, compared with medical treatment alone.
More details Read more about DEFER study and the 5-year follow-upExperience an entirely new level of productivity with: our FFR products
About Opsens Medical
Established in 2003, Opsens Medical, a division of Opsens (TSX:OPS) was founded on the belief that our innovative technologies will help to improve cardiovascular disease treatment.
Our ground-breaking solutions are designed to improve your success rate in the most challenging peripheral and coronary interventions. We combine the most innovative and reliable fiber optic sensing technology with advanced guidewire materials construction so that you can accomplish more in less procedure time and with lower overall cost.
Our goal is the same as yours: better outcomes.
News & Events
See all- 28 Nov
- OPSENS REPORTS Q4 and FY2018 RESULTS - RECORD ANNUAL REVENUE SURPASS $24 M AND RECORD QUARTERLY FFR REVENUES AT $4.1 M
- 27 Nov
- OPSENS RECEIVES HEALTH CANADA APPROVAL FOR dPR INTENDED FOR THE DIAGNOSIS OF CORONARY STENOSIS WITH THE HEART AT REST
- 08 Nov
- OPSENS – FIRST USE OF dPR FOR THE DIAGNOSIS OF CORONARY STENOSIS WITH THE HEART AT REST